Dr. Lal PathLabs has announced a board meeting scheduled for January 30, 2026, to review and approve the unaudited standalone and consolidated financial results for the quarter and nine months ending December 31, 2025. The trading window for company securities will be closed from January 1, 2026, until February 1, 2026.
Board Meeting Announcement
A meeting of the Board of Directors of Dr. Lal PathLabs is scheduled to be held on January 30, 2026. The purpose of the meeting is to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company.
Financial Results Discussion
The board will discuss the financial performance for the Quarter and Nine Months ending on December 31, 2025.
Trading Window Closure
In accordance with the company’s insider trading policies, the Trading Window for dealing in the company’s securities will be closed from January 1, 2026, to February 1, 2026 (both days inclusive). This closure applies to all individuals covered under the company’s code of conduct.
Source: BSE
